<code id='EAD230DABC'></code><style id='EAD230DABC'></style>
    • <acronym id='EAD230DABC'></acronym>
      <center id='EAD230DABC'><center id='EAD230DABC'><tfoot id='EAD230DABC'></tfoot></center><abbr id='EAD230DABC'><dir id='EAD230DABC'><tfoot id='EAD230DABC'></tfoot><noframes id='EAD230DABC'>

    • <optgroup id='EAD230DABC'><strike id='EAD230DABC'><sup id='EAD230DABC'></sup></strike><code id='EAD230DABC'></code></optgroup>
        1. <b id='EAD230DABC'><label id='EAD230DABC'><select id='EAD230DABC'><dt id='EAD230DABC'><span id='EAD230DABC'></span></dt></select></label></b><u id='EAD230DABC'></u>
          <i id='EAD230DABC'><strike id='EAD230DABC'><tt id='EAD230DABC'><pre id='EAD230DABC'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:fashion    Page View:2377
          A person walks past the Palantir sign. -- health tech coverage from STAT
          FABRICE COFFRINI/AFP via Getty Images

          PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services. 

          Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools. 

          advertisement

          For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care. 

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Diversify hospital leadership teams to protect BIPOC patient health
          Diversify hospital leadership teams to protect BIPOC patient health

          AdobeLastyear,myfather,aJamaicanimmigrantwithMedicaidinsurance,passedawayfromaheartattack.Hewasonly6

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          House transparency, PBM reform bill gains bipartisan support

          Rep.FrankPallone(D-N.J.)J.ScottApplewhite/APWASHINGTON—ADemocrathassignedontoalegislativepackagethat